Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.004 AUD | 0.00% |
|
0.00% | +14.29% |
Mar. 25 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
Mar. 14 | Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+14.29% | 8.27M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Avecho Biotechnology Begins Manufacturing for Oral Cannabidiol Capsules